The Quest for Synergistic Effects with Novel Agents Treating metastatic or Advanced Melanoma Treatment requires systemic disease control, and the current therapeutic landscape is defined by the strategic use of combination regimens. While checkpoint inhibitors have been transformative, not all patients achieve durable responses, prompting intense research into novel agents that can create...